3D Bioprinting Market size to grow by USD 2,015.81 million from 2022 to 2027

NEW YORK, Aug. 2, 2023 /PRNewswire/ -- The 3D bioprinting market size is estimated to grow by USD 2,015.81 million from 2022 to 2027, growing at a CAGR of 19.94%. North America is estimated to account for 31% of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In 2022, North America accounted for the largest revenue share of the global 3D bioprinting market. In North America, the US and Canada are the significant revenue contributors to the market in focus. Moreover, the growth of the market in focus in the region can be attributed to enhanced healthcare infrastructure, high adoption of 3D bioprinting technologies in healthcare facilities, and the presence of established companies. For Comprehensive details on the market size of historic period(2017 to 2021) and forecast period (2023-2027) - View the Sample report

Key Developments:

Rapid advances in technology, intense competition, and changing dynamics in the market are the key factors for the intense competition among vendors.

With the rising competition, the market will see consolidation. However, manufacturing complexities and high production costs pose significant risk factors for vendors in the market.

Market Dynamics

Major Drivers & Challenges

The advancements in 3D bioprinting technology are notably driving the 3D bioprinting market growth. The 3D bioprinting market is being significantly fueled by the continued progress in 3D bioprinting technologies, such as better bio-ink formulations, printing methods, and tissue engineering strategies. Such advancements permit the creation of more complex and functional tissue structures, which will change the field of regeneration medicine. The new formulations of bio-inks enhance cell survival, promote tissue fusion and make it more comfortable to construct structures that are personalized for each patient. Moreover, advancements in printing methods, including the use of multiple printheads or extruders, enable the simultaneous deposition of several cell types and materials, delivering more accurate and intricate tissue constructs. Moreover, creative approaches to tissue engineering, e.g., bioprinting on pre-pasteurized substrates or the application of thin fibrin networks, deliver exciting options for building strong and efficient tissues. Thus, the emergence of 3D bioprint technology is boosting market growth and driving boundaries for regenerative medicine and personalized health care by improving the likelihood that tissues or organs will be developed in accordance with both physiological and therapeutic needs. Therefore, such factors are expected to drive market growth during the forecast period.

The inability of researchers to combine vascular supply in printed tissues and organs is a major challenge impeding market growth. Despite significant advancements in the 3D bioprinting market, the complete bioprinting of fully functional organs or tissues for transplant remains a challenge. While researchers have successfully bioprinted parts of organs or tissues with functional cells, integrating vascular veins within the printed organs remains a hurdle. Though vascular veins can be printed separately, the bioprinted product requires a vascular system and proper blood flow for optimal functionality. The current limitations on vascular integration restrict the thickness and viability of the printed tissue. Until a viable and fully intact organ is developed for transplantation, the growth of the 3D bioprinting market may be constrained. Commercial availability of this technology to end users is not anticipated in the foreseeable future, making the challenge of integrating blood vessel supply a potential hindrance to the market's growth over the forecast period.

Key Trends

The fabrication of complex tissues is an emerging trend shaping market growth. A significant trend in the global 3D bioprinting market is the focus on fabricating complex tissues and multi-organ complexes. Researchers are exploring the simultaneous printing of various cell types, extracellular matrix, and growth hormones to create functioning tissues with intricate structures. The development of such multi-organ complexes and complex tissues has promising implications for personalized healthcare and regenerative medicine. As a result, this trend is expected to strongly influence the market's growth over the forecast period.

Technavio has identified key trends, drivers, and challenges in the market, which will help clients improve their strategies to stay ahead of their competitors. - View Sample Report

Vendor LandscapeThe 3D bioprinting market is fragmented; the vendors are competing with competitors and are trying to get greater market share. The market is growing, and the chances of new entrants cannot be overlooked. The major vendors have well-established economies of scale and market presence and generally rely on positioning technological advances, and the price of the products -The report provides a full list of key vendors, their strategies, and the latest developments. Buy NowCompany Profiles

The 3D bioprinting market report includes information on the product launches, sustainability, and prospects of leading vendors including 3D Bioprinting Solutions, 3D Systems Corp., Advanced Solutions Inc., Aspect Biosystems Ltd., BICO Group AB, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal Inc., Foldink, GE Healthcare Technologies Inc., Hangzhou Jienuofei Biotechnology Co. Ltd., Inventia Life Science Pty Ltd., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Poietis, Precise Bio Inc., regenHU Ltd., and ROKIT Healthcare Inc.

Competitive Analysis

The report includes competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others.

Market Segmentation

This 3D bioprinting market report extensively covers market segmentation by application (human tissue and organ generation, medical testing, dental, prosthetics, and others), solution (3D bioprinters, bioprinting materials, and services and ancillary equipment), and geography (North America, Europe, Asia, and Rest of World (ROW)).

The market share growth by the human tissue and organ generation segment will be significant during the forecast period. Human tissue and organ generation through 3D bioprinting holds the potential to reduce the waiting time for patients in need of organ transplants and minimize the risk of implant rejection. While the technology is still in its developmental stage, significant progress has been made, with the successful creation of a human kidney in laboratories and research organizations. Although human trials for bioprinted organs were not ready until 2017, the demand for 3D bioprinting in this application is expected to increase and drive the growth of the market in focus during the forecast period.

Technavio's SUBSCRIPTION platform

Related Reports:

The 3D mapping and modeling market size is estimated to grow at a CAGR of 15.24% between 2022 and 2027. The 3D mapping and modeling market size is forecast to increase by USD 7,086.65 million. This report extensively covers market segmentation by component (software and services), product (3D modeling and 3D mapping), and geography (North America, APAC, Europe, Middle East and Africa, and South America). The growing use of 3D mapping and modeling in building and construction is notably driving market growth.

The 3D imaging market share is expected to increase by USD 29.17 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 17.5%. This report extensively covers the 3D imaging market segmentation by application (healthcare, media and entertainment, industrial, defense, and others) and geography (North America, Europe, APAC, South America, and Middle East and Africa). One of the key factors driving growth in the 3D imaging market is the increasing product launches.

3D Bioprinting Market Scope

Report Coverage

Details

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 19.94%

Market growth 2023-2027

USD 2,015.81 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

19.82

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 31%

Key countries

US, Canada, Germany, China, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

3D Bioprinting Solutions, 3D Systems Corp., Advanced Solutions Inc., Aspect Biosystems Ltd., BICO Group AB, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal Inc., Foldink, GE Healthcare Technologies Inc., Hangzhou Jienuofei Biotechnology Co. Ltd., Inventia Life Science Pty Ltd., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Poietis, Precise Bio Inc., regenHU Ltd., and ROKIT Healthcare Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of contents

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition

3.2 Market segment analysis

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027

4 Historic Market Size

4.1 Global 3D bioprinting market 2017 - 2021

4.2 Application Segment Analysis 2017 - 2021

4.3 Solution Segment Analysis 2017 - 2021

4.4 Geography Segment Analysis 2017 - 2021

4.5 Country Segment Analysis 2017 - 2021

5 Five Forces Analysis

5.1 Five forces summary

5.2 Bargaining power of buyers

5.3 Bargaining power of suppliers

5.4 Threat of new entrants

5.5 Threat of substitutes

5.6 Threat of rivalry

5.7 Market condition

6 Market Segmentation by Application

6.1 Market segments

6.2 Comparison by Application

6.3 Human tissue and organ generation - Market size and forecast 2022-2027

6.4 Medical testing - Market size and forecast 2022-2027

6.5 Dental - Market size and forecast 2022-2027

6.6 Prosthetics - Market size and forecast 2022-2027

6.7 Others - Market size and forecast 2022-2027

6.8 Market opportunity by Application

7 Market Segmentation by Solution

7.1 Market segments

7.2 Comparison by Solution

7.3 3D bioprinters - Market size and forecast 2022-2027

7.4 Bioprinting materials - Market size and forecast 2022-2027

7.5 Services and ancillary equipment - Market size and forecast 2022-2027

7.6 Market opportunity by Solution

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation

9.2 Geographic comparison

9.3 North America - Market size and forecast 2022-2027

9.4 Europe - Market size and forecast 2022-2027

9.5 Asia - Market size and forecast 2022-2027

9.6 Rest of World (ROW) - Market size and forecast 2022-2027

9.7 US - Market size and forecast 2022-2027

9.8 China - Market size and forecast 2022-2027

9.9 Germany - Market size and forecast 2022-2027

9.10 Canada - Market size and forecast 2022-2027

9.11 Japan - Market size and forecast 2022-2027

9.12 Market opportunity by geography

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape

11.3 Landscape disruption

11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered

12.2 Market positioning of vendors

12.3 3D Bioprinting Solutions

12.4 3D Systems Corp.

12.5 Advanced Solutions Inc.

12.6 Aspect Biosystems Ltd.

12.7 BICO Group AB

12.8 CollPlant Biotechnologies Ltd.

12.9 Cyfuse Biomedical K.K.

12.10 Desktop Metal Inc.

12.11 GE Healthcare Technologies Inc.

12.12 Hangzhou Jienuofei Biotechnology Co. Ltd.

12.13 Inventia Life Science Pty Ltd.

12.14 Organovo Holdings Inc.

12.15 Poietis

12.16 regenHU Ltd.

12.17 ROKIT Healthcare Inc.

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist

13.3 Currency conversion rates for US$

13.4 Research methodology

13.5 List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: [email protected]: www.technavio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/3d-bioprinting-market-size-to-grow-by-usd-2-015-81-million-from-2022-to-2027advancements-in-3d-bioprinting-technology-to-drive-the-market---technavio-301889463.html

SOURCE Technavio

Desktop Health introduces the PrintRoll rotating build platform

The global inkjet print head market is expected to reach an estimated $3.8 billion by 2028 with a CAGR of 4.9% from 2023 to 2028